Publication:
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology.

dc.contributor.authorNadarajah, Ramesh
dc.contributor.authorLudman, Peter
dc.contributor.authorLaroche, Cécile
dc.contributor.authorAppelman, Yolande
dc.contributor.authorBrugaletta, Salvatore
dc.contributor.authorBudaj, Andrzej
dc.contributor.authorBueno, Hector
dc.contributor.authorHuber, Kurt
dc.contributor.authorKunadian, Vijay
dc.contributor.authorLeonardi, Sergio
dc.contributor.authorLettino, Maddalena
dc.contributor.authorMilasinovic, Dejan
dc.contributor.authorGale, Chris P
dc.date.accessioned2023-09-15T08:25:21Z
dc.date.available2023-09-15T08:25:21Z
dc.date.issued2023-09-12
dc.description.abstractBACKGROUND The majority of NSTEMI burden resides outside high-income countries (HICs). We describe presentation, care, and outcomes of NSTEMI by country income classification. METHODS AND RESULTS Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by World Bank country income classification. Quality of care was evaluated based on 12 guideline-recommended care interventions. The all-or-none scoring composite performance measure was used to define receipt of optimal care. Outcomes included in-hospital acute heart failure, stroke/transient ischaemic attack, and death, and 30-day mortality. Patients admitted with NSTEMI in low to lower-middle-income countries (LLMICs), compared with patients in HICs, were younger, more commonly diabetic, and current smokers, but with a lower burden of other comorbidities, and 76.7% met very high risk criteria for an immediate invasive strategy. Invasive coronary angiography use increased with ascending income classification (LLMICs, 79.2%; upper middle income countries [UMICs], 83.7%; HICs, 91.0%), but overall care quality did not (≥80% of eligible interventions achieved: LLMICS, 64.8%; UMICs 69.6%; HICs 55.1%). Rates of acute heart failure (LLMICS, 21.3%; UMICs, 12.1%; HICs, 6.8%; P < 0.001), stroke/transient ischaemic attack (LLMICS: 2.5%; UMICs: 1.5%; HICs: 0.9%; P = 0.04), in-hospital mortality (LLMICS, 3.6%; UMICs: 2.8%; HICs: 1.0%; P < 0.001) and 30-day mortality (LLMICs, 4.9%; UMICs, 3.9%; HICs, 1.5%; P < 0.001) exhibited an inverse economic gradient. CONCLUSION Patients with NSTEMI in LLMICs present with fewer comorbidities but a more advanced stage of acute disease, and have worse outcomes compared with HICs. A cardiovascular health narrative is needed to address this inequity across economic boundaries.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipSince the start of EORP, the following companies have supported the programme: Abbott Vascular Int. (2011–20), Amgen Cardiovascular (2009–18), AstraZeneca (2014–21), Bayer AG (2009–18), Boehringer Ingelheim (2009–19), Boston Scientific (2009–12), the Bristol Myers Squibb and Pfizer Alliance (2011–19), Daiichi Sankyo Europe GmbH (2011–20), the Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2014–17), Edwards (2016–19), Gedeon Richter Plc. (2014–16), Menarini Int. Op. (2009–12), MSD-Merck & Co. (2011–14), Novartis Pharma AG (2014–20), ResMed (2014–16), Sanofi (2009–11), Servier (2009–21), Vifor (2019–22).es_ES
dc.format.number6es_ES
dc.format.page552es_ES
dc.format.volume9es_ES
dc.identifier.citationEur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):552-563.es_ES
dc.identifier.doi10.1093/ehjqcco/qcad008es_ES
dc.identifier.e-issn2058-1742es_ES
dc.identifier.journalEuropean heart journal. Quality of care & clinical outcomeses_ES
dc.identifier.pubmedID36737420es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16461
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.relation.publisherversion10.1093/ehjqcco/qcad008es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Investigación Cardiovascular Traslacional Multidisciplinariaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshNon-ST Elevated Myocardial Infarctiones_ES
dc.subject.meshIschemic Attack, Transientes_ES
dc.subject.meshHeart Failurees_ES
dc.subject.meshCardiologyes_ES
dc.subject.meshStrokees_ES
dc.subject.meshHumanses_ES
dc.subject.meshProspective Studieses_ES
dc.subject.meshRegistrieses_ES
dc.titlePresentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication4e417023-fc1f-41d2-8130-485f76466465
relation.isAuthorOfPublication.latestForDiscovery4e417023-fc1f-41d2-8130-485f76466465

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Presentation_care_and_outcomes_Eur Heart J Qual Care Clin Outcomes_2023.pdf
Size:
1.14 MB
Format:
Adobe Portable Document Format
Description:
Artículo